ANTICOAGULANT ACTIVITY OF TISSUE FACTOR PATHWAY INHIBITOR COMPARED WITH OTHER ANTICOAGULANTS

被引：0

作者：

NORDFANG, O ^{[1
]}

KRISTENSEN, H ^{[1
]}

VALENTIN, S ^{[1
]}

OSTERGAARD, P ^{[1
]}

机构：

[1] NOVO NORDISK AS,GENTOFTE,DENMARK

来源：

CIRCULATION | 1992年 / 86卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：815 / 815

页数：1

共 50 条

[41] Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity [J].

Pinotti, M ;

Bertolucci, C ;

Portaluppi, F ;

Colognesi, I ;

Frigato, E ;

Foà, A ;

Bernardi, F .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (03) :646-649

[42] PROCOAGULANT ACTIVITY IN BRONCHOALVEOLAR FLUIDS - NO RELATIONSHIP WITH TISSUE FACTOR PATHWAY INHIBITOR ACTIVITY [J].

DEMOERLOOSE, P ;

DEBENEDETTI, E ;

NICOD, L ;

VIFIAN, C ;

REBER, G .

THROMBOSIS RESEARCH, 1992, 65 (4-5) :507-518

[43] Recombinant human tissue factor pathway inhibitor as a possible anticoagulant targeting hepatic sinusoidal walls [J].

Yamanobe, F ;

Mochida, S ;

Ohno, A ;

Ishikawa, K ;

Fujiwara, K .

THROMBOSIS RESEARCH, 1997, 85 (06) :493-501

[44] HEPARIN-RELEASABLE TISSUE FACTOR PATHWAY INHIBITOR (TFPI) - IMPLICATIONS IN THE OVERALL ANTICOAGULANT RESPONSES [J].

FASANELLA, T ;

MALINOWSKA, K ;

JESKE, W ;

CALLAS, D ;

HOPPENSTEADT, D ;

FAREED, J .

FASEB JOURNAL, 1994, 8 (05) :A641-A641

[45] Tissue factor pathway inhibitor (TFPI) has strong anticoagulant and antithrombotic actions in vitro and in vivo [J].

Kaiser, B ;

Hoppenstead, DH ;

Walenga, JM ;

Glusa, E ;

Fareed, J .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) :R284-R284

[46] Localization of tissue factor pathway inhibitor to lipid rafts is not required for inhibition of factor VIIa/tissue factor activity [J].

Dietzen, DJ ;

Jack, GG ;

Page, KL ;

Tetzloff, TA ;

Hall, CL ;

Mast, AE .

THROMBOSIS AND HAEMOSTASIS, 2003, 89 (01) :65-73

[47] Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls [J].

Blann, AD ;

Amiral, J ;

McCollum, CN ;

Lip, GYH .

ATHEROSCLEROSIS, 2000, 152 (01) :29-34

[48] Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor [J].

Puy, Cristina ;

Tucker, Erik I. ;

Matafonov, Anton ;

Cheng, Qiufang ;

Zientek, Keith D. ;

Gailani, Dave ;

Gruber, Andras ;

McCarty, Owen J. T. .

BLOOD, 2015, 125 (09) :1488-1496

[49] ACTIVATED FACTOR XI INCREASES THE PROCOAGULANT ACTIVITY OF THE EXTRINSIC PATHWAY BY INACTIVATING TISSUE FACTOR PATHWAY INHIBITOR [J].

Puy, C. ;

Tucker, E. I. ;

Gailani, D. ;

Gruber, A. ;

McCarty, O. J. T. .

THROMBOSIS RESEARCH, 2014, 133 :S6-S6

[50] PROTAMINE NEUTRALIZATION OF THE RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR ACTIVITY BY HEPARINS [J].

HARENBERG, J ;

SIEGELE, M ;

DEMPFLE, CE ;

STEHLE, G ;

HEENE, DL .

THROMBOSIS AND HAEMOSTASIS, 1993, 70 (06) :942-945

← 1 2 3 4 5 →